| ID | Sequence | Length | GC content |
|---|---|---|---|
| PVT1:19 | AGGGCUGGGUCGCGUGUCCUGGCAGGGCCACAGGAAGAGCAUACACAUC… | 221 nt | 0.5113 |
| PVT1:2 | CCCCGCGCUCCUCCGGGCAGAGCGCGUGUGGCGGCCGAGCACAUGGGCC… | 855 nt | 0.5544 |
| PVT1:20 | CCCUAAGGACCAUAGCUGUCUGCAGUGCAGGAAGCCAACUAUUAAGGGG… | 806 nt | 0.5124 |
| PVT1:21 | CCCUAAGGACCAUAGCUGUCUGCAGUGCAGGAAGCCAACUAUUAAGGGG… | 1218 nt | 0.5312 |
| PVT1:22 | UUAGCACAGUGCUUAGCUUGGAAGCCAAAGCCCAGAGGGGUAGAAUGAC… | 1561 nt | 0.4177 |
| PVT1:23 | CUCAAGAUGGCUGUGCCUGUCAGCUGCAUGGAGCUUCGUUCAAGUAUUU… | 1699 nt | 0.5221 |
| PVT1:24 | GUCAGCUGCAUGGAGCUUCGUUCAAGUAUUUUCUGAGCCUGAUGGAUUU… | 584 nt | 0.5000 |
| PVT1:25 | UCUGAGCCUGAUGGAUUUACAGUGAUCUUCAGUGGUCUGGGGAAUAACG… | 542 nt | 0.4760 |
| PVT1:26 | AGGGUUGAGAUCUCUGUUUACUUAGAUCUCUGCCAACUUCCUUUGGGUC… | 518 nt | 0.4865 |
| PVT1:27 | GAUUCAGGGCCAGCAGCUGCAGCUUCCCUUUCCCUGCCUCUGACUUGCC… | 230 nt | 0.4739 |
This gene represents a long non-coding RNA locus that has been identified as a candidate oncogene. Increased copy number and overexpression of this gene are associated with many types of cancers including breast and ovarian cancers, acute myeloid leukemia and Hodgkin lymphoma. Allelic variants of this gene are also associated with end-stage renal disease attributed to type 1 diabetes. Consistent with its association with various types of cancer, transcription of this gene is regulated by the tumor suppressor p53 through a canonical p53-binding site, and it has been implicated in regulating levels of the proto-oncogene MYC to promote tumorigenesis. [provided by RefSeq, Sep 2015]
A study in mice demonstrated that the PVT1 was upregulated in response to intermediate- to high-dose whole-body X-ray irradiation at 16- and 24-hour time points in blood, identifying it as a p53-associated lncRNA for radiation biodosimetry [Aryankalayil et al. DOI:10.1667/RR14891.1]. In a separate investigation of myocardial ischemia-reperfusion injury in mice, the PVT1 was significantly upregulated in cardiac tissues and hypoxic cardiomyocytes, classifying it among the top differentially expressed lncRNAs in this pathological context [Luo et al. DOI:10.3389/fcell.2021.615950].